Insider Transactions in Q3 2021 at Nant Health, Inc. (NH)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2021
|
Ronald Allen Louks Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,200
-3.91%
|
$9,200
$1.96 P/Share
|
|
Sep 13
2021
|
Ronald Allen Louks Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,200
+3.77%
|
$0
$0.55 P/Share
|
|
Sep 10
2021
|
Ronald Allen Louks Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,320
-3.14%
|
$14,640
$2.05 P/Share
|
|
Sep 10
2021
|
Ronald Allen Louks Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,320
+3.04%
|
$0
$0.55 P/Share
|
|
Sep 08
2021
|
Ronald Allen Louks Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,700
-2.04%
|
$9,400
$2.25 P/Share
|
|
Sep 08
2021
|
Ronald Allen Louks Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,700
+2.0%
|
$0
$0.55 P/Share
|
|
Sep 07
2021
|
Ronald Allen Louks Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
16,613
-6.85%
|
$33,226
$2.3 P/Share
|
|
Sep 07
2021
|
Ronald Allen Louks Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,613
+6.41%
|
$0
$0.55 P/Share
|
|
Sep 03
2021
|
Ronald Allen Louks Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,505
-0.66%
|
$3,010
$2.34 P/Share
|
|
Sep 03
2021
|
Ronald Allen Louks Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,505
+0.66%
|
$0
$0.55 P/Share
|